首页 > 最新文献

Journal of Vascular Surgery最新文献

英文 中文
Employing magnetic resonance histology for precision chronic limb-threatening ischemia treatment planning 利用磁共振组织学精确制定慢性肢体缺血治疗计划。
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.08.054
Judit Csore MD, PhD , Madeline Drake MD , Christof Karmonik PhD , Bright Benfor MD , Peter Osztrogonacz MD , Alan B. Lumsden MD , Trisha L. Roy MD, PhD

Objective

Recent randomized controlled trials have demonstrated a notable prevalence of immediate technical failures in percutaneous vascular interventions (PVIs) for complex arterial lesions associated with chronic limb-threatening ischemia. Current imaging modalities present inherent limitations in identifying these lesions, making it challenging to determine the most suitable candidates for PVI. We present a novel preprocedural magnetic resonance imaging (MRI) histology protocol for identifying lesions that might present a higher rate of immediate and midterm PVI failure.

Methods

We enrolled 22 patients (13 females, average age 65.8 ± 9.72 years) scheduled for PVI were prospectively and underwent 3T MRI using ultrashort echo time and steady-state free precession contrasts to characterize target lesions before PVI. Lesions were scored as hard if >50% of the lumen was occluded by hard components (calcium/dense collagen) on MRI in the hardest cross-section. Two readers evaluated MRI datasets. Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC)/Global Limb Anatomic Staging System (GLASS)/Wound, Ischemia and Foot infection scoring was performed based on intraprocedural angiograms and chart review. The relationship between MRI scoring, TASC/GLASS scoring, and procedural outcomes was investigated using univariate analysis. Midterm follow-up (revascularization and amputation rates) was recorded at 3 and 6 months after the intervention.

Results

Our cohort of 22 patients yielded 40 target lesions. Five lesions were excluded (two for nondiagnostic image quality; three PVIs were ultimately diagnostic only). Six lesions (17%) were scored as hard. MRI-scored hard lesions had a higher proportion of immediate technical failure (hard vs soft 83% [5/6] vs 3% [1/29]; P < .001). Hard vs soft MRI scoring was the only factor significantly associated with immediate PVI technical success (P < .001), as opposed to TASC/GLASS scoring. Both at 3 months and 6 months after PVI, the reintervention rate was significantly higher among those lesions which were scored hard on MRI (3 months hard, 80% vs soft, 16% [P =.011]; 6 months hard, 80% vs soft, 27%; P = .047).

Conclusions

MRI histology could be a valuable tool for optimizing PVI patient selection and treatment strategies.
目的:最近的随机对照试验表明,在治疗与慢性肢体缺血(CLTI)相关的复杂动脉病变的经皮血管介入治疗(PVI)中,即时技术失败(ITF)的发生率很高。目前的成像模式在识别这些病变方面存在固有的局限性,这使得确定最适合进行经皮血管介入治疗的病变候选者具有挑战性。我们提出了一种新的术前磁共振成像(MRI)组织学方案,用于识别可能会导致较高的即刻和中期 PVI 失败率的病变。方法:22 名计划进行 PVI 的患者(13 名女性,平均年龄(65.8±9.72)岁)接受了前瞻性登记,并在 PVI 前使用超短回波时间和 "稳态自由前冲 "对比度进行了 3T 磁共振成像,以确定靶病变的特征。如果在最硬横截面的磁共振成像中,有>50%的管腔被硬成分(钙/致密胶原)堵塞,则病变被评为 "硬"。两名阅读者对核磁共振成像数据集进行评估。TASC/GLASS/WIFi评分是根据术中血管造影和病历审查进行的。通过单变量分析研究了 MRI 评分、TASC/GLASS 评分和手术结果之间的关系。干预后3个月和6个月的中期随访(血管再通率和截肢率)均有记录:结果:22 名患者共发现了 40 个目标病灶。5处病变被排除在外(2处图像质量无法诊断,3处PVI最终只能诊断)。6个病灶(17%)被评为 "硬 "病灶。核磁共振成像评分为 "硬 "的病灶ITF比例更高("硬 "与 "软"83%(n/N=5/6)对3%(n/N=1/29),P结论:磁共振成像组织学可能是优化PVI患者选择和治疗策略的重要工具。
{"title":"Employing magnetic resonance histology for precision chronic limb-threatening ischemia treatment planning","authors":"Judit Csore MD, PhD ,&nbsp;Madeline Drake MD ,&nbsp;Christof Karmonik PhD ,&nbsp;Bright Benfor MD ,&nbsp;Peter Osztrogonacz MD ,&nbsp;Alan B. Lumsden MD ,&nbsp;Trisha L. Roy MD, PhD","doi":"10.1016/j.jvs.2024.08.054","DOIUrl":"10.1016/j.jvs.2024.08.054","url":null,"abstract":"<div><h3>Objective</h3><div>Recent randomized controlled trials have demonstrated a notable prevalence of immediate technical failures in percutaneous vascular interventions (PVIs) for complex arterial lesions associated with chronic limb-threatening ischemia. Current imaging modalities present inherent limitations in identifying these lesions, making it challenging to determine the most suitable candidates for PVI. We present a novel preprocedural magnetic resonance imaging (MRI) histology protocol for identifying lesions that might present a higher rate of immediate and midterm PVI failure.</div></div><div><h3>Methods</h3><div>We enrolled 22 patients (13 females, average age 65.8 ± 9.72 years) scheduled for PVI were prospectively and underwent 3T MRI using ultrashort echo time and steady-state free precession contrasts to characterize target lesions before PVI. Lesions were scored as hard if &gt;50% of the lumen was occluded by hard components (calcium/dense collagen) on MRI in the hardest cross-section. Two readers evaluated MRI datasets. Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC)/Global Limb Anatomic Staging System (GLASS)/Wound, Ischemia and Foot infection scoring was performed based on intraprocedural angiograms and chart review. The relationship between MRI scoring, TASC/GLASS scoring, and procedural outcomes was investigated using univariate analysis. Midterm follow-up (revascularization and amputation rates) was recorded at 3 and 6 months after the intervention.</div></div><div><h3>Results</h3><div>Our cohort of 22 patients yielded 40 target lesions. Five lesions were excluded (two for nondiagnostic image quality; three PVIs were ultimately diagnostic only). Six lesions (17%) were scored as hard. MRI-scored hard lesions had a higher proportion of immediate technical failure (hard vs soft 83% [5/6] vs 3% [1/29]; <em>P</em> &lt; .001). Hard vs soft MRI scoring was the only factor significantly associated with immediate PVI technical success (<em>P</em> &lt; .001), as opposed to TASC/GLASS scoring. Both at 3 months and 6 months after PVI, the reintervention rate was significantly higher among those lesions which were scored hard on MRI (3 months hard, 80% vs soft, 16% [<em>P</em> =.011]; 6 months hard, 80% vs soft, 27%; <em>P</em> = .047).</div></div><div><h3>Conclusions</h3><div>MRI histology could be a valuable tool for optimizing PVI patient selection and treatment strategies.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Pages 351-363.e3"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11745931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142108784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of balloon and self-expandable stents for common femoral artery stenosis 球囊和自膨胀支架治疗股总动脉狭窄的评估。
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.09.017
Camil-Cassien Bamdé MD , Yann Goueffic MD, PhD , Comlan Blitti MD , Julien Die Loucou MD , Alain Lalande MD, PhD , Aline Laubriet-Jazayeri PhD , Charles Guenancia MD, PhD , Eric Steinmetz MD, PhD

Background

Endovascular treatment of the common femoral artery (CFA) and its bifurcation is currently recommended for patients with hostile groin (prior femoral bifurcation open surgery, history of radiotherapy) or severe comorbidities (advanced age, frailty, obesity). Preliminary results have shown favorable outcomes. Among the different endovascular techniques (atherectomy, intravascular lithotripsy, plain balloon angioplasty, drug-coated balloon angioplasty, stenting), stents are mainly used but the best type of stent to use is still debated. The aim of this study was to assess the value of balloon-expandable stents (BES) and self-expandable stents (SES) for stenosis of the femoral bifurcation.

Methods

Consecutive patients with stenosis of the CFA and its bifurcation were included from 2016 to 2022. Demographic data, the type of stent used, procedural data, and angiographic variables were collected. Groups were defined according to the type of stent implanted. Primary patency was defined as a binary end point based on a duplex ultrasound peak systolic velocity ratio of ≤2.4 as assessed by duplex ultrasound examination, in the absence of clinically driven target lesion revascularization (TLR) or bypass of the target lesion. Secondary outcomes were clinical sustained improvement, freedom from TLR at 12 months, mean ankle-brachial index improvement, primary-assisted patency, and secondary patency.

Results

A total of 90 procedures conducted in 77 patients were included in this study, 26 in the SES group and 64 in the BES group. The most common symptomatology according to the Rutherford classification was class 2, 3, and 4 (28%, 48%, and 8%, respectively). The type of lesions in the CFA, assessed using the Azema classification, were comparable between both groups (SES/BES group type 2: 31%/27%; type 3: 54%/62%). At 12 months, the primary patency rates for SES and BES were 88% (26/26 patients) and 72% (58/64 patients) (P = .10). At 12 months, freedom from TLR rates for SES and BES were 97% vs 81%, respectively (P = .13).

Conclusions

SES for CFA stenosis show a trend toward better patency and freedom from TLR rates at 12 months. However, controlled studies are warranted to further investigate the significance of this trend.
背景:目前,股总动脉及其分叉处的血管内治疗建议用于腹股沟有敌意(曾接受股骨分叉处开放手术、放疗史)(5) 或严重合并症(高龄、虚弱、肥胖)的患者。初步结果显示疗效良好(7)。在不同的血管内技术(动脉粥样硬化切除术、血管内碎石术(IVL)、普通球囊血管成形术、药物涂层球囊血管成形术、支架置入术)中,支架是主要的应用手段,但使用哪种支架最好仍存在争议。本研究旨在评估球囊扩张支架(BES)和自扩张支架(SES)对股动脉分叉狭窄的价值:纳入2016年至2022年期间连续收治的CFA及其分叉狭窄患者。收集了人口统计学数据、使用的支架类型、手术数据和血管造影变量。根据植入支架的类型定义分组。主要通畅率被定义为二元终点,即在没有临床驱动的靶病变血管再通或靶病变搭桥的情况下,双相超声评估的收缩速度峰值比为2.4或更低。次要结果是临床持续改善、12 个月内无靶病变血管再通(TLR)、平均 ABI 改善、主要辅助通畅率和次要通畅率:共有 77 名患者接受了 90 例手术,其中 SES 组 26 例,BES 组 64 例。根据卢瑟福分类法,最常见的症状为2级、3级和4级(分别占28%、48%和8%)。根据 AZEMA 分类法评估的 CFA 病变类型在两组之间具有可比性(SES/BES 组 2 类:31%/27%;3 类:54%/62%)。12 个月时,SES 和 BES 的主要通畅率分别为 88%(26/26 例患者)和 72%(58/64 例患者)(P=0.10)。12个月后,SES和BES的无靶病变血运重建率(TLR)分别为97%和81%(P=0.13):结论:自扩支架治疗 CFA 狭窄显示出更好的通畅性趋势,12 个月后的无 TLR 率也更高。然而,要进一步研究这一趋势的意义,还需要进行对照研究。
{"title":"Evaluation of balloon and self-expandable stents for common femoral artery stenosis","authors":"Camil-Cassien Bamdé MD ,&nbsp;Yann Goueffic MD, PhD ,&nbsp;Comlan Blitti MD ,&nbsp;Julien Die Loucou MD ,&nbsp;Alain Lalande MD, PhD ,&nbsp;Aline Laubriet-Jazayeri PhD ,&nbsp;Charles Guenancia MD, PhD ,&nbsp;Eric Steinmetz MD, PhD","doi":"10.1016/j.jvs.2024.09.017","DOIUrl":"10.1016/j.jvs.2024.09.017","url":null,"abstract":"<div><h3>Background</h3><div>Endovascular treatment of the common femoral artery (CFA) and its bifurcation is currently recommended for patients with hostile groin (prior femoral bifurcation open surgery, history of radiotherapy) or severe comorbidities (advanced age, frailty, obesity). Preliminary results have shown favorable outcomes. Among the different endovascular techniques (atherectomy, intravascular lithotripsy, plain balloon angioplasty, drug-coated balloon angioplasty, stenting), stents are mainly used but the best type of stent to use is still debated. The aim of this study was to assess the value of balloon-expandable stents (BES) and self-expandable stents (SES) for stenosis of the femoral bifurcation.</div></div><div><h3>Methods</h3><div>Consecutive patients with stenosis of the CFA and its bifurcation were included from 2016 to 2022. Demographic data, the type of stent used, procedural data, and angiographic variables were collected. Groups were defined according to the type of stent implanted. Primary patency was defined as a binary end point based on a duplex ultrasound peak systolic velocity ratio of ≤2.4 as assessed by duplex ultrasound examination, in the absence of clinically driven target lesion revascularization (TLR) or bypass of the target lesion. Secondary outcomes were clinical sustained improvement, freedom from TLR at 12 months, mean ankle-brachial index improvement, primary-assisted patency, and secondary patency.</div></div><div><h3>Results</h3><div>A total of 90 procedures conducted in 77 patients were included in this study, 26 in the SES group and 64 in the BES group. The most common symptomatology according to the Rutherford classification was class 2, 3, and 4 (28%, 48%, and 8%, respectively). The type of lesions in the CFA, assessed using the Azema classification, were comparable between both groups (SES/BES group type 2: 31%/27%; type 3: 54%/62%). At 12 months, the primary patency rates for SES and BES were 88% (26/26 patients) and 72% (58/64 patients) (<em>P</em> = .10). At 12 months, freedom from TLR rates for SES and BES were 97% vs 81%, respectively (<em>P</em> = .13).</div></div><div><h3>Conclusions</h3><div>SES for CFA stenosis show a trend toward better patency and freedom from TLR rates at 12 months. However, controlled studies are warranted to further investigate the significance of this trend.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Pages 397-407"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142349236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Midterm single-center results with the use of custom-made endografts with inner branches, a call for attention 使用带内分支的定制内移植物的单中心中期结果值得关注。
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.09.039
Jose I. Torrealba MD , Giuseppe Panuccio MD, PhD , Petroula Nana PhD , Antonino Giordano MD , Daour Yousef Al Sarhan MD , Tilo Kölbel MD, PhD

Objective

The aim of this study was to evaluate the patency of bridging covered stents (BCS) bridged to inner branches in custom-made thoracoabdominal endografts.

Methods

This was a single-center retrospective study identifying all patients undergoing fenestrated or branched endovascular aortic repair (f/b EVAR) in whom the reno-visceral target vessels (TVs) were bridged with a BCS to an inner branch of a custom-made (CMD) endograft. Technical success and perioperative complications were noted. Follow-up BCS patencies were evaluated, and in patients with follow-up, two groups based on BCS were created, a group with BCS occlusion and a group with BCS patent. Univariable and multivariable analyses were performed to analyze factors related to visceral and renal bridging stent occlusion.

Results

From 2019 through 2022, 69 patients undergoing complex aortic repair had at least one TV bridged to an inner branch built into a CMD endograft. Eighty-six percent of the grafts had only inner branches, whereas 14% had a mix of fenestrations for the visceral TVs and inner branches for the renal arteries. Twenty-five percent of patients presented as urgent and received an endograft originally designed for another patient and available on our shelf at the time. A total of 245 TVs were connected to inner branches: celiac trunk (CT), 54; superior mesenteric artery (SMA), 59; and renal artery (RA), 132. Technical success was 99%. There was a 23% complication and 9% perioperative mortality rate. At follow-up, we identified 6% of visceral and 14% of renal BCS occlusions. The primary patency for RA BCS was 83% at 12 months and 58% at 24 months. For the CT-SMA BCS, Kaplan-Maier showed a patency of 99% and 96% at 12 and 24 months. In the univariate analysis, a misaligned TV ostium (P = .001), the postoperative BCS diameter on postoperative computed tomography angiography (P = .02), and the preoperative infrarenal aortic angle >60° (P = .007) were correlated with RA BCS occlusion. In the multivariate analysis, only the misaligned TV ostium (P = .002) and infrarenal angle >60° (P = .01) were significantly correlated.

Conclusions

In our series of complex aortic repair, the incorporation of inner branches to bridge TVs is associated with a high renal BCS occlusion rate. Improper alignment of the branches with the TV ostium and acute aortic angles might play a significant role. Further research on this technology is needed.
目的评估桥接覆盖支架(BCS)桥接定制胸腹腔内支架内分支的通畅性:方法:单中心回顾性研究,确定所有接受栅栏式或分支式血管内主动脉修复术(f/b EVAR)的患者,这些患者的内脏靶血管(TV)与定制的(CMD)内移植物的内分支之间使用了桥接覆盖支架(BCS)。研究人员注意到了技术成功率和围手术期并发症。对随访的BCS通畅情况进行了评估,并根据BCS通畅情况将随访患者分为两组:BCS闭塞组和BCS通畅组。对内脏和肾脏桥接支架闭塞的相关因素进行了单变量和多变量分析:2019-2022年,69名接受复杂主动脉修复术的患者至少有一个TV桥接到了CMD内移植物的内支。86%的移植物仅有内支,而14%的内脏TV和肾动脉内支混合使用。25%的患者因病情紧急而接受了原本为另一位患者设计的内植物移植,当时我们的货架上就有这种内植物。245 例内脏 TV 与内脏分支相连:腹腔干 (CT) 54 例,肠系膜上动脉 (SMA) 59 例,肾动脉 (RA) 132 例。技术成功率为 99%。并发症发生率为 23%,围手术期死亡率为 9%。在随访中,我们发现内脏 BCS 闭塞率为 6%,肾脏 BCS 闭塞率为 14%。12个月和24个月时,RA BCS的主要通畅率分别为83%和58%。对于 CT-SMA BCS,Kaplan-Maier(KM)显示 12 个月和 24 个月的通畅率分别为 99% 和 96%。在单变量分析中,TV骨膜错位(P 0.001)、术后CTA显示的术后BCS直径(P 0.02)和术前肾下主动脉夹角大于60º(0.007)与RA BCS闭塞相关。在多变量分析中,只有TV骨膜错位(P 0.002)和肾下角度>60°(P 0.01)与RA BCS闭塞显著相关:结论:在我们的复杂主动脉修复系列中,采用内分支桥接TV与较高的肾脏BCS闭塞率有关。分支与电视骨膜对位不当以及急性主动脉夹角可能是重要原因。这项技术还需要进一步研究。
{"title":"Midterm single-center results with the use of custom-made endografts with inner branches, a call for attention","authors":"Jose I. Torrealba MD ,&nbsp;Giuseppe Panuccio MD, PhD ,&nbsp;Petroula Nana PhD ,&nbsp;Antonino Giordano MD ,&nbsp;Daour Yousef Al Sarhan MD ,&nbsp;Tilo Kölbel MD, PhD","doi":"10.1016/j.jvs.2024.09.039","DOIUrl":"10.1016/j.jvs.2024.09.039","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to evaluate the patency of bridging covered stents (BCS) bridged to inner branches in custom-made thoracoabdominal endografts.</div></div><div><h3>Methods</h3><div>This was a single-center retrospective study identifying all patients undergoing fenestrated or branched endovascular aortic repair (f/b EVAR) in whom the reno-visceral target vessels (TVs) were bridged with a BCS to an inner branch of a custom-made (CMD) endograft. Technical success and perioperative complications were noted. Follow-up BCS patencies were evaluated, and in patients with follow-up, two groups based on BCS were created, a group with BCS occlusion and a group with BCS patent. Univariable and multivariable analyses were performed to analyze factors related to visceral and renal bridging stent occlusion.</div></div><div><h3>Results</h3><div>From 2019 through 2022, 69 patients undergoing complex aortic repair had at least one TV bridged to an inner branch built into a CMD endograft. Eighty-six percent of the grafts had only inner branches, whereas 14% had a mix of fenestrations for the visceral TVs and inner branches for the renal arteries. Twenty-five percent of patients presented as urgent and received an endograft originally designed for another patient and available on our shelf at the time. A total of 245 TVs were connected to inner branches: celiac trunk (CT), 54; superior mesenteric artery (SMA), 59; and renal artery (RA), 132. Technical success was 99%. There was a 23% complication and 9% perioperative mortality rate. At follow-up, we identified 6% of visceral and 14% of renal BCS occlusions. The primary patency for RA BCS was 83% at 12 months and 58% at 24 months. For the CT-SMA BCS, Kaplan-Maier showed a patency of 99% and 96% at 12 and 24 months. In the univariate analysis, a misaligned TV ostium (<em>P</em> = .001), the postoperative BCS diameter on postoperative computed tomography angiography (<em>P</em> = .02), and the preoperative infrarenal aortic angle &gt;60° (<em>P</em> = .007) were correlated with RA BCS occlusion. In the multivariate analysis, only the misaligned TV ostium (<em>P</em> = .002) and infrarenal angle &gt;60° (<em>P</em> = .01) were significantly correlated.</div></div><div><h3>Conclusions</h3><div>In our series of complex aortic repair, the incorporation of inner branches to bridge TVs is associated with a high renal BCS occlusion rate. Improper alignment of the branches with the TV ostium and acute aortic angles might play a significant role. Further research on this technology is needed.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Pages 310-317"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142468755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of open and endovascular repair of complex abdominal aortic aneurysms 复杂腹主动脉瘤开放式和血管内修复术的比较。
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.10.016
Sai Divya Yadavalli MD , Vinamr Rastogi MD , Ambar Mehta MD , Sara Allievi MD , Yoel Solomon MD , Jorg L. de Bruin MD, PhD , Shipra Arya MD, SM , Lars Stangenberg MD, PhD , Hence J.M. Verhagen MD, PhD , Marc L. Schermerhorn MD

Objective

The aim of this study was to compare perioperative and 5-year outcomes following endovascular (FEVAR) and open repair (OAR) of complex abdominal aortic aneurysms (cAAAs) in males and females separately, given the known sex-related differences in perioperative outcomes.

Methods

We studied all elective cAAA repairs between 2014 and 2019 in the Vascular Implant Surveillance and Interventional Outcomes Network (VISION) registry. We stratified patients based on sex. We calculated propensity scores for assignment to either OAR or FEVAR. Covariates including age, race, diameter, baseline comorbidities, proximal extent of repair, annual center volumes, and annual surgeon volumes were introduced into the model for estimating propensity scores. Within matched cohorts, perioperative outcomes and 5-year outcomes (mortality, reinterventions, and ruptures) were evaluated using multivariable logistic and Cox regression models.

Results

We identified 2825 patients, of whom 29% were female. Within both the sexes, OAR was more commonly performed (OAR vs FEVAR: males: 53% vs 47%; females: 63% vs 37%). After matching, among males (n = 1326), FEVAR was associated with lower perioperative mortality (FEVAR vs OAR: 2.3% vs 5.1%; P < .001). However, FEVAR was associated with comparable 5-year mortality (38% vs 28%; hazard ratio [HR], 1.2; 95% confidence interval [CI], 0.92-1.4; P = .22) and a higher hazard of 5-year reintervention (19% vs 3.7%; adjusted HR, 4.5; 95% CI, 2.6-7.6; P < .001). Among females (n = 456), FEVAR and OAR showed similar perioperative mortality (8.3% vs 7.0%; P = .73). At 5 years, FEVAR was associated with higher hazards of mortality (43% vs 32%; adjusted HR, 1.5; 95% CI, 1.03-2.2; P = .034) and reintervention (20% vs 3.0%; adjusted HR, 4.8; 95% CI, 2.1-11; P < .001) compared with OAR.

Conclusions

Among males, FEVAR was associated with favorable perioperative outcomes compared with OAR, although these advantages attenuate over time. However, among females, FEVAR was associated with similar perioperative outcomes, eventually leading to higher reinterventions and possibly higher mortality within 5 years. Future efforts should focus on determining the factors associated with these sex disparities to improve outcomes following FEVAR in females. Based on current evidence, females undergoing elective cAAA repair should be selected with due caution, especially for endovascular repair.
目的考虑到围术期结果中已知的性别差异,比较复杂腹主动脉瘤(cAAA)的血管内(FEVAR)和开放式修复(OAR)术后男性和女性的围术期和5年结果:我们研究了血管植入监测和介入治疗结果网络(VISION)登记处 2014-2019 年间所有选择性 cAAA 修复术。我们根据性别对患者进行了分层。我们计算了分配到 OAR 或 FEVAR 的倾向分数。在估计倾向分数的模型中引入了包括年龄、种族、直径、基线合并症、近端修复范围、中心年手术量和外科医生年手术量在内的协变量。在匹配队列中,使用多变量逻辑和 Cox 回归模型对围手术期结果和 5 年结果(死亡率、再介入治疗和破裂)进行了评估:我们确定了 2825 名患者,其中 29% 为女性。在男女患者中,OAR 更为常见(OAR vs FEVAR:男性:53% vs 47%;女性:63% vs 37%)。匹配后,在男性(n=1326)中,FEVAR 的围手术期死亡率较低(FEVAR vs OAR:2.3% vs 5.1%;p结论:在男性中,与 OAR 相比,FEVAR 具有良好的围手术期预后,尽管这些优势会随着时间的推移而减弱。然而,在女性中,FEVAR 的围手术期结果与 OAR 相似,但最终会导致更高的再介入率,并可能在 5 年内导致更高的死亡率。未来的工作重点应该是确定与这些性别差异相关的因素,以改善女性 FEVAR 术后的预后。根据目前的证据,女性接受选择性 cAAA 修复术时应适当谨慎,尤其是血管内修复术。
{"title":"Comparison of open and endovascular repair of complex abdominal aortic aneurysms","authors":"Sai Divya Yadavalli MD ,&nbsp;Vinamr Rastogi MD ,&nbsp;Ambar Mehta MD ,&nbsp;Sara Allievi MD ,&nbsp;Yoel Solomon MD ,&nbsp;Jorg L. de Bruin MD, PhD ,&nbsp;Shipra Arya MD, SM ,&nbsp;Lars Stangenberg MD, PhD ,&nbsp;Hence J.M. Verhagen MD, PhD ,&nbsp;Marc L. Schermerhorn MD","doi":"10.1016/j.jvs.2024.10.016","DOIUrl":"10.1016/j.jvs.2024.10.016","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to compare perioperative and 5-year outcomes following endovascular (FEVAR) and open repair (OAR) of complex abdominal aortic aneurysms (cAAAs) in males and females separately, given the known sex-related differences in perioperative outcomes.</div></div><div><h3>Methods</h3><div>We studied all elective cAAA repairs between 2014 and 2019 in the Vascular Implant Surveillance and Interventional Outcomes Network (VISION) registry. We stratified patients based on sex. We calculated propensity scores for assignment to either OAR or FEVAR. Covariates including age, race, diameter, baseline comorbidities, proximal extent of repair, annual center volumes, and annual surgeon volumes were introduced into the model for estimating propensity scores. Within matched cohorts, perioperative outcomes and 5-year outcomes (mortality, reinterventions, and ruptures) were evaluated using multivariable logistic and Cox regression models.</div></div><div><h3>Results</h3><div>We identified 2825 patients, of whom 29% were female. Within both the sexes, OAR was more commonly performed (OAR vs FEVAR: males: 53% vs 47%; females: 63% vs 37%). After matching, among males (n = 1326), FEVAR was associated with lower perioperative mortality (FEVAR vs OAR: 2.3% vs 5.1%; <em>P</em> &lt; .001). However, FEVAR was associated with comparable 5-year mortality (38% vs 28%; hazard ratio [HR], 1.2; 95% confidence interval [CI], 0.92-1.4; <em>P</em> = .22) and a higher hazard of 5-year reintervention (19% vs 3.7%; adjusted HR, 4.5; 95% CI, 2.6-7.6; <em>P</em> &lt; .001). Among females (n = 456), FEVAR and OAR showed similar perioperative mortality (8.3% vs 7.0%; <em>P</em> = .73). At 5 years, FEVAR was associated with higher hazards of mortality (43% vs 32%; adjusted HR, 1.5; 95% CI, 1.03-2.2; <em>P</em> = .034) and reintervention (20% vs 3.0%; adjusted HR, 4.8; 95% CI, 2.1-11; <em>P</em> &lt; .001) compared with OAR.</div></div><div><h3>Conclusions</h3><div>Among males, FEVAR was associated with favorable perioperative outcomes compared with OAR, although these advantages attenuate over time. However, among females, FEVAR was associated with similar perioperative outcomes, eventually leading to higher reinterventions and possibly higher mortality within 5 years. Future efforts should focus on determining the factors associated with these sex disparities to improve outcomes following FEVAR in females. Based on current evidence, females undergoing elective cAAA repair should be selected with due caution, especially for endovascular repair.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Pages 287-297.e2"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142468809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular strategies for the short distance between the lowest renal artery and aortic bifurcation 最低肾动脉与主动脉分叉之间短距离的血管内策略。
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.09.010
Mitri K. Khoury MD, Adam W. Beck MD, Mark A. Farber MD, F. Ezequiel Parodi MD, Warren Gasper MD, W. Anthony Lee MD, Gustavo Oderich MD, Andres Schanzer MD, Darren Schneider MD, Mathew Sweet MD, Carlos H. Timaran MD, Matthew J. Eagleton MD
{"title":"Endovascular strategies for the short distance between the lowest renal artery and aortic bifurcation","authors":"Mitri K. Khoury MD,&nbsp;Adam W. Beck MD,&nbsp;Mark A. Farber MD,&nbsp;F. Ezequiel Parodi MD,&nbsp;Warren Gasper MD,&nbsp;W. Anthony Lee MD,&nbsp;Gustavo Oderich MD,&nbsp;Andres Schanzer MD,&nbsp;Darren Schneider MD,&nbsp;Mathew Sweet MD,&nbsp;Carlos H. Timaran MD,&nbsp;Matthew J. Eagleton MD","doi":"10.1016/j.jvs.2024.09.010","DOIUrl":"10.1016/j.jvs.2024.09.010","url":null,"abstract":"","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Pages 508-509"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Open thoracic aortic aneurysm sac exploration following thoracic endovascular aortic repair and fenestrated branched endovascular aortic repair: New hybrid approach to fixing the Achilles heel of endovascular repair, while raising new questions 胸主动脉腔内修复及开窗支血管腔内修复术后开胸动脉瘤囊探查:修复血管腔内修复阿喀琉斯的新混合方法,同时也提出了新的问题。
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.09.032
Sukgu M. Han MD, MS
{"title":"Open thoracic aortic aneurysm sac exploration following thoracic endovascular aortic repair and fenestrated branched endovascular aortic repair: New hybrid approach to fixing the Achilles heel of endovascular repair, while raising new questions","authors":"Sukgu M. Han MD, MS","doi":"10.1016/j.jvs.2024.09.032","DOIUrl":"10.1016/j.jvs.2024.09.032","url":null,"abstract":"","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Pages 308-309"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reflections on innovation, excellence and service in clinical vascular surgery 血管外科临床创新、卓越与服务的思考。
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.10.066
M. Ashraf Mansour MD, MBA, FACS
{"title":"Reflections on innovation, excellence and service in clinical vascular surgery","authors":"M. Ashraf Mansour MD, MBA, FACS","doi":"10.1016/j.jvs.2024.10.066","DOIUrl":"10.1016/j.jvs.2024.10.066","url":null,"abstract":"","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Pages 273-279"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial, biological sex, and geographic disparities of venous thromboembolism in the United States, 2016 to 2019
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.10.079
A.M. Afifi, M. Leverich, K. Tadrousse, G. Ren, M. Nazzal
{"title":"Racial, biological sex, and geographic disparities of venous thromboembolism in the United States, 2016 to 2019","authors":"A.M. Afifi,&nbsp;M. Leverich,&nbsp;K. Tadrousse,&nbsp;G. Ren,&nbsp;M. Nazzal","doi":"10.1016/j.jvs.2024.10.079","DOIUrl":"10.1016/j.jvs.2024.10.079","url":null,"abstract":"","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Page A15"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143127984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the treatment strategies for symptomatic chronic internal carotid artery occlusion 有症状的慢性颈内动脉闭塞治疗策略比较
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.05.062
Fei Mei MD, PhD , Wuming Zhang MD , Peng Jiang MD , Chengpeng Tan MD , Yongpan Cui MD , Jiawei Fan MD , Wayne W. Zhang MD

Objective

The best management of symptomatic chronic internal carotid artery occlusion (CICAO) has been controversial. This systematic review and meta-analysis were to compare the outcomes of different treatment strategies for symptomatic CICAO.

Methods

Two independent researchers conducted a search of articles on the treatment of CICAO published between January 2000 and October 2023 in PubMed, Web of Science, Embase, and The Cochrane Library. Twenty-two articles were eligible for meta-analysis using a random effects model to combine and analyze the data for the pooled rates of stroke and death, and the rates of procedural success and significant restenosis/occlusion.

Results

A total of 1193 patients from 22 publications were included in this study. Six of them had bilateral internal carotid artery occlusion. The 30-day stroke and death rates were 1.1% (95% confidence interval [CI], 0%-4.4%) in the best medical treatment (BMT) group, 4.1% (95% CI, 0.7%-9.3%; I2 = 71.4%) in the extracranial-intracranial (EC-IC) bypass group, 4.4% (95% CI, 2.4%-6.8%; I2 = 0%) in the carotid artery stenting (CAS) group, and 1.2% (95% CI, 0%-3.4%; I2 = 0%) in the combined carotid endarterectomy (CEA) and stenting (CEA + CAS) group. During follow-up of 16.5 (±16.3) months, the stroke and death rates were 19.5%, 1.2%, 6.6%, and 2.4% in the BMT, EC-IC, CAS, and CEA + CAS groups respectively. The surgical success rate was 99.7% (95% CI, 98.5%-100%; I2 = 0%) in the EC-IC group, 70.1% (95% CI, 62.3%-77.5%; I2 = 64%) in the CAS group, and 86.4% (95% CI, 78.8%-92.7%; I2 = 60%) in the CEA + CAS group. The rate of post-procedural significant restenosis or occlusion was 3.6% in the EC-IC group, 18.7% in the CAS group, and 5.7% in the CEA + CSA group. The surgical success rate was negatively associated by the length of internal carotid artery (ICA) occlusion. Surgical success rate was significantly higher in the patients with occlusive lesion within C1 to C4 segments, compared with those with occlusion distal to C4 segment (odds ratio, 11.3; 95% CI, 5.0-25.53; P < .001). A proximal stump of ICA is a favorable sign for CAS. The success rate of CAS was significantly higher in the patients with an ICA stump than that in the patients without (odds ratio, 11.36; 95% CI, 4.84-26.64; P < .01). However, the success rate of CEA + CAS was not affected by the proximal ICA stump.

Conclusions

For the management of symptomatic CICAO, BMT alone is associated with the highest risk of mid- and long-term stroke and death. EC-IC bypass surgery and CEA + CAS should be considered as the choice of treatment based on operator’s expertise and patient’s anatomy. CAS may be employed as an alternative option in high surgical risk patients, especially when proximal ICA stump exists.
背景:症状性慢性颈内动脉闭塞症(CICAO)的最佳治疗方法一直存在争议。本系统综述和荟萃分析旨在比较无症状 CICAO 不同治疗策略的疗效:两名独立研究人员检索了 2000 年 1 月至 2023 年 10 月期间在 PubMed、Web of Science、Embase 和 Cochrane 图书馆发表的有关 CICAO 治疗的文章。22篇文章符合荟萃分析的条件,采用随机效应模型对中风和死亡的汇总率以及手术成功率和明显的再狭窄/闭塞率进行了合并和数据分析:本研究共纳入了22篇文献中的1193名患者。结果:本研究共纳入了 22 篇文献中的 1193 例患者,其中 6 例为双侧颈内动脉闭塞。最佳内科治疗(BMT)组的 30 天卒中率和死亡率为 1.1%(95%CI:0%-4.4%),颅外-颅内(EC-IC)搭桥组为 4.1%(95%CI:0.7%-9.3%,I2=71.4%),颅内-颅外(EC-IC)搭桥组为 4.4%(95%CI:2.4% - 6.8%,I2=0%),颈动脉支架植入术(CAS)组为1.2%(95%CI:0% - 3.4%,I2=0%),颈动脉内膜剥脱术和支架植入术联合术(CEA+CAS)组为1.2%(95%CI:0% - 3.4%,I2=0%)。在16.5(±16.3)个月的随访期间,BMT组、EC-IC组、CAS组和CEA+CAS组的卒中率和死亡率分别为19.5%、1.2%、6.6%和2.4%。EC-IC组的手术成功率为99.7%(95%CI:98.5%-100%,I2=0%),CAS组为70.1%(95%CI:62.3%-77.5%,I2=64%),CEA+CAS组为86.4%(95%CI:78.8%-92.7%,I2=60%)。EC-IC组的术后明显再狭窄或闭塞率为3.6%,CAS组为18.7%,CEA+CSA组为5.7%。手术成功率与颈内动脉(ICA)闭塞长度呈负相关。与 C4 段远端闭塞的患者相比,C1 至 C4 段闭塞患者的手术成功率明显更高(OR:11.3,95%CI:5.0-25.53,PConclusions:对于有症状的 CICAO 的治疗,单纯 BMT 与中长期卒中和死亡的最高风险相关。应根据操作者的专业知识和患者的解剖结构选择 EC-IC 搭桥手术和 CEA+CAS 作为治疗方案。对于手术风险较高的患者,尤其是存在近端 ICA 残端时,可选择 CAS。
{"title":"Comparison of the treatment strategies for symptomatic chronic internal carotid artery occlusion","authors":"Fei Mei MD, PhD ,&nbsp;Wuming Zhang MD ,&nbsp;Peng Jiang MD ,&nbsp;Chengpeng Tan MD ,&nbsp;Yongpan Cui MD ,&nbsp;Jiawei Fan MD ,&nbsp;Wayne W. Zhang MD","doi":"10.1016/j.jvs.2024.05.062","DOIUrl":"10.1016/j.jvs.2024.05.062","url":null,"abstract":"<div><h3>Objective</h3><div>The best management of symptomatic chronic internal carotid artery occlusion (CICAO) has been controversial. This systematic review and meta-analysis were to compare the outcomes of different treatment strategies for symptomatic CICAO.</div></div><div><h3>Methods</h3><div>Two independent researchers conducted a search of articles on the treatment of CICAO published between January 2000 and October 2023 in PubMed, Web of Science, Embase, and The Cochrane Library. Twenty-two articles were eligible for meta-analysis using a random effects model to combine and analyze the data for the pooled rates of stroke and death, and the rates of procedural success and significant restenosis/occlusion.</div></div><div><h3>Results</h3><div>A total of 1193 patients from 22 publications were included in this study. Six of them had bilateral internal carotid artery occlusion. The 30-day stroke and death rates were 1.1% (95% confidence interval [CI], 0%-4.4%) in the best medical treatment (BMT) group, 4.1% (95% CI, 0.7%-9.3%; I<sup>2</sup> = 71.4%) in the extracranial-intracranial (EC-IC) bypass group, 4.4% (95% CI, 2.4%-6.8%; I<sup>2</sup> = 0%) in the carotid artery stenting (CAS) group, and 1.2% (95% CI, 0%-3.4%; I<sup>2</sup> = 0%) in the combined carotid endarterectomy (CEA) and stenting (CEA + CAS) group. During follow-up of 16.5 (±16.3) months, the stroke and death rates were 19.5%, 1.2%, 6.6%, and 2.4% in the BMT, EC-IC, CAS, and CEA + CAS groups respectively. The surgical success rate was 99.7% (95% CI, 98.5%-100%; I<sup>2</sup> = 0%) in the EC-IC group, 70.1% (95% CI, 62.3%-77.5%; I<sup>2</sup> = 64%) in the CAS group, and 86.4% (95% CI, 78.8%-92.7%; I<sup>2</sup> = 60%) in the CEA + CAS group. The rate of post-procedural significant restenosis or occlusion was 3.6% in the EC-IC group, 18.7% in the CAS group, and 5.7% in the CEA + CSA group. The surgical success rate was negatively associated by the length of internal carotid artery (ICA) occlusion. Surgical success rate was significantly higher in the patients with occlusive lesion within C1 to C4 segments, compared with those with occlusion distal to C4 segment (odds ratio, 11.3; 95% CI, 5.0-25.53; <em>P</em> &lt; .001). A proximal stump of ICA is a favorable sign for CAS. The success rate of CAS was significantly higher in the patients with an ICA stump than that in the patients without (odds ratio, 11.36; 95% CI, 4.84-26.64; <em>P</em> &lt; .01). However, the success rate of CEA + CAS was not affected by the proximal ICA stump.</div></div><div><h3>Conclusions</h3><div>For the management of symptomatic CICAO, BMT alone is associated with the highest risk of mid- and long-term stroke and death. EC-IC bypass surgery and CEA + CAS should be considered as the choice of treatment based on operator’s expertise and patient’s anatomy. CAS may be employed as an alternative option in high surgical risk patients, especially when proximal ICA stump exists.</div></div>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Pages 494-504.e2"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controversies in the management strategy for symptomatic chronic internal carotid artery occlusion 症状性慢性颈内动脉闭塞治疗策略的争议。
IF 3.9 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.jvs.2024.07.029
Ali F. AbuRahma MD
{"title":"Controversies in the management strategy for symptomatic chronic internal carotid artery occlusion","authors":"Ali F. AbuRahma MD","doi":"10.1016/j.jvs.2024.07.029","DOIUrl":"10.1016/j.jvs.2024.07.029","url":null,"abstract":"","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":"81 2","pages":"Page 505"},"PeriodicalIF":3.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Vascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1